Noh D, et al. - Researchers conducted this trial to assess if the early anatomical and visual acuity (VA) responses to intravitreal bevacizumab (IVB) correlated with 1-year follow-up outcomes in patients with macular edema secondary to branch retinal vein occlusion (BRVO). As per the findings, the anatomical and functional improvement at 12 months and the early anatomical and functional response were interconnected.